Q1 venture financing round-up: IVD still attracts top private equity dollars; ophthalmology stirs more interest than imaging
This article was originally published in Clinica
Executive Summary
As we moved towards the end of 2010, the investment landscape was looking healthier than it was a year before. Clinica noted that over a third of the private equity financing deals that it covered in the second half of 2010 involved double-digit figures, and half of those deals were between $20-40m (www.clinica.co.uk, 1 February 2011).